Selected research
Industry Research
Cholera Vaccine (Oral Route) Industry Research Report 2026
Market perspective
The global Cholera Vaccine (Oral Route) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cholera Vaccine (Oral Route) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cholera Vaccine (Oral Route) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cholera Vaccine (Oral Route) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cholera Vaccine (Oral Route) include EuBiologics, PaxVax, Valneva and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cholera Vaccine (Oral Route) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cholera Vaccine (Oral Route) Market by Company
EuBiologics
PaxVax
Valneva
Sanofi
Cholera Vaccine (Oral Route) Segment by Type
Dukoral
Shanchol
Vaxchora
Others
Cholera Vaccine (Oral Route) Segment by Application
Pharmaceutical & Biotechnology Companies
Hospital
Research & Academic Laboratories
Others
Cholera Vaccine (Oral Route) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholera Vaccine (Oral Route) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cholera Vaccine (Oral Route) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholera Vaccine (Oral Route).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cholera Vaccine (Oral Route) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cholera Vaccine (Oral Route) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dukoral
- Shanchol
- Vaxchora
- Others
Applications
- Pharmaceutical & Biotechnology Companies
- Hospital
- Research & Academic Laboratories
- Others
Companies covered
- EuBiologics
- PaxVax
- Valneva
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cholera Vaccine (Oral Route) Market Size (2021-2032)
- 2.2.2 Global Cholera Vaccine (Oral Route) Sales (2021-2032)
- 2.2.3 Global Cholera Vaccine (Oral Route) Market Average Price (2021-2032)
- 2.3 Cholera Vaccine (Oral Route) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Dukoral
- 2.3.3 Shanchol
- 2.3.4 Vaxchora
- 2.3.5 Others
- 2.4 Cholera Vaccine (Oral Route) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical & Biotechnology Companies
- 2.4.3 Hospital
- 2.4.4 Research & Academic Laboratories
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cholera Vaccine (Oral Route) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cholera Vaccine (Oral Route) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cholera Vaccine (Oral Route) Revenue of Manufacturers (2021-2026)
- 3.4 Global Cholera Vaccine (Oral Route) Average Price by Manufacturers (2021-2026)
- 3.5 Global Cholera Vaccine (Oral Route) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cholera Vaccine (Oral Route), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cholera Vaccine (Oral Route), Product Type & Application
- 3.8 Global Manufacturers of Cholera Vaccine (Oral Route), Established Date
- 3.9 Global Cholera Vaccine (Oral Route) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 EuBiologics
- 4.1.1 EuBiologics Company Information
- 4.1.2 EuBiologics Business Overview
- 4.1.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 EuBiologics Cholera Vaccine (Oral Route) Product Portfolio
- 4.1.5 EuBiologics Recent Developments
- 4.2 PaxVax
- 4.2.1 PaxVax Company Information
- 4.2.2 PaxVax Business Overview
- 4.2.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 PaxVax Cholera Vaccine (Oral Route) Product Portfolio
- 4.2.5 PaxVax Recent Developments
- 4.3 Valneva
- 4.3.1 Valneva Company Information
- 4.3.2 Valneva Business Overview
- 4.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Valneva Cholera Vaccine (Oral Route) Product Portfolio
- 4.3.5 Valneva Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Company Information
- 4.4.2 Sanofi Business Overview
- 4.4.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Cholera Vaccine (Oral Route) Product Portfolio
- 4.4.5 Sanofi Recent Developments
5 Global Cholera Vaccine (Oral Route) Market Scenario by Region
- 5.1 Global Cholera Vaccine (Oral Route) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cholera Vaccine (Oral Route) Sales by Region: 2021-2032
- 5.2.1 Global Cholera Vaccine (Oral Route) Sales by Region: 2021-2026
- 5.2.2 Global Cholera Vaccine (Oral Route) Sales by Region: 2027-2032
- 5.3 Global Cholera Vaccine (Oral Route) Revenue by Region: 2021-2032
- 5.3.1 Global Cholera Vaccine (Oral Route) Revenue by Region: 2021-2026
- 5.3.2 Global Cholera Vaccine (Oral Route) Revenue by Region: 2027-2032
- 5.4 North America Cholera Vaccine (Oral Route) Market Facts & Figures by Country
- 5.4.1 North America Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
- 5.4.3 North America Cholera Vaccine (Oral Route) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cholera Vaccine (Oral Route) Market Facts & Figures by Country
- 5.5.1 Europe Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
- 5.5.3 Europe Cholera Vaccine (Oral Route) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cholera Vaccine (Oral Route) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cholera Vaccine (Oral Route) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cholera Vaccine (Oral Route) Market Facts & Figures by Country
- 5.7.1 South America Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
- 5.7.3 South America Cholera Vaccine (Oral Route) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cholera Vaccine (Oral Route) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cholera Vaccine (Oral Route) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cholera Vaccine (Oral Route) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cholera Vaccine (Oral Route) Sales by Type (2021-2032)
- 6.1.1 Global Cholera Vaccine (Oral Route) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2021-2032)
- 6.2 Global Cholera Vaccine (Oral Route) Revenue by Type (2021-2032)
- 6.2.1 Global Cholera Vaccine (Oral Route) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2021-2032)
- 6.3 Global Cholera Vaccine (Oral Route) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cholera Vaccine (Oral Route) Sales by Application (2021-2032)
- 7.1.1 Global Cholera Vaccine (Oral Route) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2021-2032)
- 7.2 Global Cholera Vaccine (Oral Route) Revenue by Application (2021-2032)
- 7.2.1 Global Cholera Vaccine (Oral Route) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2021-2032)
- 7.3 Global Cholera Vaccine (Oral Route) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cholera Vaccine (Oral Route) Value Chain Analysis
- 8.1.1 Cholera Vaccine (Oral Route) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cholera Vaccine (Oral Route) Production Mode & Process
- 8.2 Cholera Vaccine (Oral Route) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cholera Vaccine (Oral Route) Distributors
- 8.2.3 Cholera Vaccine (Oral Route) Customers
9 Global Cholera Vaccine (Oral Route) Analyzing Market Dynamics
- 9.1 Cholera Vaccine (Oral Route) Industry Trends
- 9.2 Cholera Vaccine (Oral Route) Industry Drivers
- 9.3 Cholera Vaccine (Oral Route) Industry Opportunities and Challenges
- 9.4 Cholera Vaccine (Oral Route) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst